Sino Biopharmaceutical (HK:1177) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Sino Biopharmaceutical’s subsidiary, Chia Tai Tianqing, has purchased 16.8 million shares as part of its Share Incentive Scheme, representing 0.09% of the company’s total shares. This initiative is aimed at implementing share-based incentives for selected participants, with shares valued at approximately HKD3.65 each, totaling around HKD61.26 million. The board continues to review and determine future share distributions under this scheme.
For further insights into HK:1177 stock, check out TipRanks’ Stock Analysis page.
